Abcam Announces Winner of 15 Discoveries Contest

  • Contest celebrates scientific breakthroughs with $15,000 research grant

Cambridge UK, February 3, 2013: Abcam plc., a global leader in the supply of innovative protein research tools, today announced Yali Huang as the winner of its 15 discoveries contest. Ms. Huang conducts her work at the Early Embryo Development lab at the MRC Centre of Regenerative Medicine, University of Edinburgh, Scotland. The contest recognises the most innovative and exciting scientific breakthroughs of the last 18 months supported by Abcam products.

In recognition of her winning entry, Ms. Huang’s lab will receive a $15,000 lab research grant and $1,000 worth of Abcam products. Her project, titled ‘In Vivo Differentiation Potential of Epiblast Stem Cells Revealed by Chimeric Embryo Formation’, was selected from over 80 global submissions by an expert panel of scientists. Illustrating the importance of the host environment on Chimera formation, the research contributes to a greater understanding of how cultured stem cells relate to the early embryo.

“We’re delighted to have won the 15 discoveries contest and would like to thank Abcam for their support in making our research project a success. At a time when budgets are under pressure the grant will be extremely beneficial to our lab, to help us further our discoveries.”

-Yali Huang, Early Embryo Development lab, MRC Centre of Regenerative Medicine, University of Edinburgh

“The 15 discoveries contest is Abcam’s way of recognising the hard work and achievements of life science researchers. We are fortunate to live in a time where, thanks to great advances in biology tools and techniques, researchers are able to make almost daily breakthroughs in our understanding of how cells operate in health and disease. Abcam’s goal is to continue supporting these breakthroughs, enabling scientists to discover more.”

– Dr. Jonathan Milner, CEO of Abcam

Abcam is committed to supporting scientists with their life science discoveries and continually looks at new ways to innovate its products and services. This includes development of pioneering research tools such as its proprietary rabbit monoclonal antibody technology, RabMAb®.

View Ms. Huang’s published article.

View contest finalists.

Contacts:

Abcam
T: +44 (0) 1223 696000

Media enquiries
Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0) 7787 502 947

Abcam to open office in Shanghai, China

  • New office will provide dedicated support to Chinese customers

Shanghai office

Cambridge UK, January 21, 2014: Abcam plc., a global leader in the supply of innovative protein research tools, has announced that it will open a new office in February 2014, in Shanghai, China. The new hub is the Company’s ninth global office, and has been established to support Abcam’s focus on increasing geographic reach and improving distribution channels to rapidly growing markets. Located in Zhangjiang Hi-Tech Park, Pudong New District, a prominent economic growth and innovation area, the office is within close proximity of the City and Abcam’s production facility in Hangzhou, which develops pioneering research tools such as RabMAb®, its proprietary rabbit monoclonal antibody technology.

The office will house customer and technical support functions, provided by native Mandarin speakers, as well as a product warehouse, which will facilitate local stock storage for the first time. This means that customers will benefit from improved delivery times, with the large majority of orders arriving at their door within 24 hours. The proximity of the office will also enable Abcam to support customers with more specific needs through its extensive range of products and services, including custom antibody production.

“China is an important market for Abcam and we’re pleased to provide enhanced services such as faster delivery and dedicated local language support to our customers. Further future investments will ensure we continue to deliver innovative products and services to enable scientists to discover more.”

– Dr. Jonathan Milner, CEO of Abcam

Contacts:

Abcam
T: +44 (0) 1223 696000

Media enquiries
Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0) 7787 502 947

Abcam wins ‘Most Admired Company’ award

  • Award from Management Today in association with BSI celebrates the highest performing companies in British business.
Abcam wins 'Most Admired Company' awardPicture shows: Alan Hirzel, Abcam’s Chief Marketing Officer, collects an award from The RT Hon the Lord Heseltine CH for the ‘Most Admired Company’ in the Healthcare and Household sector of the Management Today awards.

Cambridge UK, December 4, 2013: Abcam Plc., a leading provider of protein research tools and services, announced today it has been voted as Management Today’s ‘Most Admired Company’ in the Healthcare and Household sector. Abcam was also this year’s overall highest new entry, taking position 13 in the league table of 247 British businesses. The Britain’s Most Admired Companies Awards are an important indicator of the highest performing companies in British business that embed excellence throughout their organisation, and are unique in that the results are arrived at via a rigorous and independent process of peer review.

“It’s an exciting time for Abcam as we celebrate 15 years of supporting researchers with their scientific discoveries. We credit Abcam’s success to talented and passionate employees across the globe. Their skills and dedication to deliver the best customer service and highest quality products has helped Abcam achieve continued growth.”

– Dr. Jonathan Milner, CEO of Abcam

Abcam has already been recognised this year for its successful business model, strong growth and innovation in the market, winning the AIM 2013 ‘Company of the Year’ award. Abcam continues to help researchers discover more by attracting the best talent and bringing to market innovation such as RabMAb® (rabbit monoclonal antibodies) technology.

Contacts:

Abcam
T: +44 (0) 1223 696000

Media enquiries
Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0) 7787 502 947

Abcam Introduces Alexa Fluor Secondary Antibodies

  • New range offers increased choice for multi-colour staining
Alexa® product launchCambridge, UK, November 04 2013: Abcam Plc., a leading provider of protein research tools and services, announced today that it has added new Alexa Fluor® 405/568/750 conjugated secondary antibodies to its existing Alexa Fluor® 488/555/594/647 conjugates. Extensively tested in Abcam’s labs, the Alexa Fluor® range guarantees bright staining and low background. The different color variants were selected to provide an increased selection for multi-color staining.

The Alexa Fluor® portfolio comprises antibodies raised against mouse/rabbit/rat/chicken /goat /sheep/guinea-pig IgG and against mouse/rabbit IgM. It also includes a large selection of pre-adsorbed/cross-adsorbed and F(ab’)2 fragment secondaries to ensure low species cross-reactivity. A dilution range of 1/200 -1/1000 in IF/ICC allows for at least 250 stainings* per product to improve cost efficiency.

“The Alexa® range expansion adds a blue emitting fluorophore, Alexa Fluor® 405, and a near IR dye, Alexa Fluor® 750. The addition of Alexa Fluor® 568 is ideal for confocal laser-scanning microscopists as most of these microscopes have a 561nm laser, which optimally excites the Alexa Fluor® 568 dye. We’re pleased that we can offer our customers more dye variants and enable them to perform multi-colour imaging experiments”.

– Judith Langenick, Product Manager, Secondary Antibodies

Abcam Alexa Fluor® secondaries are ideal for cell biologists and microscopists undertaking multi-color staining from all research backgrounds. The addition of these products complements Abcam’s innovative RabMAb® (rabbit monoclonal antibodies) products and market leading primary antibody range.

Abcam Alexa Fluor® secondaries are accompanied with information-rich datasheets, fast delivery, and expert scientific support. They are available globally and can be purchased directly through the Abcam website or through one of Abcam’s authorized distributors.

Find out more about our Alexa Fluor® range »

*assuming a 1/200 dilution in 200 μl PBS

Alexa Fluor® is a registered trademark of Life Technologies. Alexa Fluor® dye conjugates contain(s) technology licensed to Abcam by Life Technologies.

Abcam Named AIM Company of the Year

  • Award celebrates achievements of a dynamic business with strong future growth prospects
Abcam AIM company fo the year 2013Picture shows left to right: David Snell, Partner and AIM Leader, PwC; Chris Fielding, Director of Corporate Finance, WH Ireland; Jonathan Milner, CEO, Abcam plc; and Sophie Raworth, Awards Presenter.

Cambridge UK, October 14, 2013: Abcam Plc., a leading provider of life science research tools, announced today it has been named ‘Company of the Year’ in the 2013 AIM Awards. The AIM awards celebrate outstanding achievement of quoted companies and entrepreneurs who have harnessed AIM to help them fulfil their ambition and growth potential in the last twelve months.

Company of the Year is the ultimate accolade for any AIM-listed company. The award is presented to the company that has best demonstrated it is a responsible, fully accountable, dynamic business with strong growth prospects and a commitment to AIM. Above all, the winner is deemed to be a well-managed business, having attracted public funding to enhance and develop its growth potential to the full.

“We’re celebrating 15 years of successful growth at Abcam in 2013, which we credit to a sustainable business model combined with attracting talented employees, who demonstrate exceptional teamwork and a shared passion for providing the best products and services to our customers across the globe. This is an exciting time for Abcam as we strive to continue to develop novel solutions to support scientists with their discoveries. I look forward to reporting Abcam’s achievements over the next 15 years.”

– Dr. Jonathan Milner, CEO of Abcam

Abcam previously won Company of the Year in the 2009 AIM Awards, and has continued to achieve strong growth and shown innovation in the market. The Company has enhanced its product range through the addition of non-primary antibodies, as well as pioneering research tools such as its proprietary rabbit monoclonal antibody technology, RabMAb®, following the acquisition of Epitomics. Abcam’s vision is to become the world’s leading supplier of life science research tools.

Contacts:

Abcam
Francesca Axe
T: +44 (0) 1223 696000

Media enquiries
Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0) 7787 502 947

Abcam Launches SimpleStep ELISA Kits

  • Kits offer enhanced performance and ease of use to accelerate immunoassay research.

Cambridge, UK, September 09 2013: Abcam plc., a producer and distributor of high quality protein research tools, announced today that it has launched a range of SimpleStep™ ELISA kits. The new kits have a greatly simplified protocol when compared to standard multi-step ELISAs, providing significant time savings and ease of use.

Abcam appoints Alan Hirzel as Chief Marketing Officer

  • New role will support future growth strategies at Abcam

Cambridge UK, June, 27, 2013: Abcam Plc., a global leader in the supply of protein research tools, announced today that it has appointed Alan Hirzel as Chief Marketing Officer. This is a new position, based at Abcam’s Headquarters in Cambridge, UK, which will strengthen Abcam’s management team and support the company in delivering its growth strategies.

Alan will take responsibility for Abcam’s branding, product portfolio and online consumer offering. He joins Abcam on 5th August 2013.

Alan has over 20 years of global business and leadership experience. Prior to joining Abcam, he spent 14 years with leading management consultant Bain & Company, most recently serving as head of the UK Healthcare Practice and head of its London office operations. Whilst at Bain, Alan advised a wide range of global brand executives on consumer and marketing strategies to help achieve growth targets.

Alan serves as a Trustee at The Social Business Trust, and has recently been appointed to the board of UK National Citizen Service. Alan has a B.S. in Plant Molecular Biology and M.S. from Cornell University, and an MBA from the Johnson Graduate School of Business at Cornell.

Jonathan Milner, CEO of Abcam, commented: “We are pleased to welcome Alan to Abcam at an exciting time for the company, which sees many new growth opportunities. Alan’s life science background, and his business and leadership experience, will be of immense value to Abcam as it continues its quest to become the world-leading life science tools company.”

Contacts:

Abcam
Francesca Axe
T: +44 (0) 1223 696000

Media enquiries
Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0) 7787 502 947

Abcam Welcomes Students from Cambridge Regional College

  • BTEC Science Diploma students take part in a series of talks and practical demonstrations at Abcam’s lab in Cambridge, UK.

Abcam Plc., a producer and distributor of high quality protein research tools, welcomed a group of students studying for the BTEC Science Diploma at Cambridge Regional College to take part in a series of activities at its Cambridge headquarters on Tuesday 26th March. The visit was designed to give the students some experience of what it is like to work in a busy, successful working laboratory.

The students enjoyed a series of educational, scientific talks from Sarah Bolt, Head of Characterisation Services, and Wyn Forrest-Owen, Head of Production Sciences, during which they learned about the production of Abcam’s products, and how scientists use the reagents in their research. Abcam’s Resourcing Advisor, Claire Warburton, also gave the students some practical tips on writing a CV and applying for jobs in the science industry. The visit finished with a tour of the laboratory where the production and testing of some of Abcam’s products takes place.

Abcam Welcomes Students from Cambridge Regional College

Claire Sellick, Biology Lecturer at Cambridge Regional College, said: “The visit has been really inspirational for our students and has helped them better understand the day-to-day running of a lab at a successful biotech company. We’re grateful to Abcam for taking the time to support and encourage our students with their studies.”

Wyn Forrest-Owen, Head of Production Sciences said: “We hope that we’ve been able to excite the next generation of scientists about their future careers in the industry. Today will have given the students a little insight into the practical skills and knowledge required to be a successful scientist.”

 

Contact information

Francesca Axe
Abcam
+44 (0) 1223 696000

Lorna Cuddon
Zyme Communications
+44 (0)7787 502 947
katie.odgaard@zymecommunications.com

Abcam donates an additional £45,000 to local charities

  • Cambridge, UK based Red Balloon, Winter Comfort, and Cambridge Community Foundation, to benefit

Cambridge, UK, March 18, 2013: Abcam Plc, producer and distributor of high quality protein research tools, today announced its support for local good causes by donating an additional £45,000 to three local charities (£15,000 each). The three charities are: Red Balloon, a charity to support the recovery of bullied children; Winter Comfort, a social initiative to help the homeless; and Cambridge Community Foundation, a local charity working to connect a range of donors to local good causes.

“Supporting our community is really important to Abcam. We’ve been incredibly fortunate over the years and are now really pleased to be able to now give something back, providing support at what is a critical point for some of these charities. We look forward to helping other good causes in the future,” commented Jonathan Milner, CEO, Abcam.

Abcam donates to Red Balloon

Jacob Gray from Abcam’s Charity Committee presents a £15,000 cheque to Carrie Herbert, Chief Executive of Red Balloon.

Abcam also regularly donates to a range of national and international causes through its Charity Committee. The Committee, which consists of Abcam employees, has been administrating funding to charities since 2004.

Rachel Newell, Social Enterprise and Business Development Manager, Wintercomfort, said: “We would like to thank Abcam for their donation. We’re looking at developing new initiatives that will give those that that are homeless or vulnerably housed the skills to help them get back into employment and this money will help support any current and future projects.”

Jane Darlington, CEO of Cambridge Community Foundation, said: “We are delighted to welcome Abcam as the latest member of our Community Foundation 100 initiative. Through this initiative we are bringing 100 local companies and people together to collectively support local voluntary and community groups that are working hard to improve the quality of life across the communities of Cambridgeshire.”

Dr. Carrie Herbert, Founder and Chief Executive of Red Balloon, said: “It is heart-warming when a successful local business supports a local charity which is now a national organization. With Abcam’s help we shall be able to grow and deliver our recovery program to severely bullied and traumatized children who are unable to go to school.” 

Contact information

Francesca Axe
Abcam
+44 (0) 1223 696000

Lorna Cuddon
Zyme Communications
+44 (0) 7811 996942

Abcam helps contribute to growth of hi-tech sector in Cambridge, UK

A recent case study by the Greater Cambridge and Greater Peterborough Enterprise Partnership showcases Abcam’s efforts in contributing to the growth of the hi-tech sector in the local region.

The Greater Cambridge Greater Peterborough Enterprise Partnership is focused on helping to drive forward sustainable economic growth in the area – with local business, education providers, the third sector and the public sector working together to achieve this.

“Abcam represents what Cambridge can offer in terms of technology and innovation.”

“We’re well networked with other forward thinking local organisations who are striving for similar goals within the hi-tech sector.”

– Chief Operating Officer, Jim Warwick